Posted by admin on Aug 7th, 2022

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) was downgraded by stock analysts at William Blair from a “market perform” rating to an “underperform” rating in a research note issued on Friday, MarketBeat Ratings reports.

Several other research firms have also weighed in on XRAY. Bank of America lowered DENTSPLY SIRONA from a “buy” rating to a “neutral” rating and lowered their price target for the stock from $66.00 to $49.00 in a research report on Tuesday, April 19th. HC Wainwright lowered their price target on DENTSPLY SIRONA from $58.00 to $48.00 and set a “hold” rating on the stock in a research report on Friday, April 22nd. Robert W. Baird downgraded DENTSPLY SIRONA from an “outperform” rating to a “neutral” rating and reduced their target price for the stock from $67.00 to $48.00 in a research note on Tuesday, April 19th. UBS Group upgraded DENTSPLY SIRONA from a “neutral” rating to a “buy” rating and reduced their target price for the stock from $58.00 to $47.00 in a research note on Wednesday, June 1st. Finally, Piper Sandler reduced their target price on DENTSPLY SIRONA from $41.00 to $38.00 in a research note on Monday, July 11th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $48.11.

Shares of DENTSPLY SIRONA stock opened at $36.84 on Friday. The business’s 50 day simple moving average is $36.56 and its 200 day simple moving average is $43.90. DENTSPLY SIRONA has a 52-week low of $33.78 and a 52-week high of $63.10. The firm has a market cap of $7.94 billion, a PE ratio of 21.80, a P/E/G ratio of 2.89 and a beta of 0.91. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.03 and a current ratio of 1.45.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last posted its quarterly earnings results on Tuesday, May 10th. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.02. The firm had revenue of $9.67 billion for the quarter, compared to analyst estimates of $982.05 million. DENTSPLY SIRONA had a return on equity of 11.63% and a net margin of 8.81%. The business’s quarterly revenue was up 841.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.72 EPS. On average, analysts predict that DENTSPLY SIRONA will post 2.41 earnings per share for the current fiscal year.

Several institutional investors have recently added to or reduced their stakes in XRAY. National Bank of Canada FI bought a new stake in DENTSPLY SIRONA in the 4th quarter valued at $55,000. National Asset Management Inc. lifted its position in shares of DENTSPLY SIRONA by 7.7% during the 4th quarter. National Asset Management Inc. now owns 4,116 shares of the medical instruments supplier’s stock valued at $230,000 after acquiring an additional 294 shares during the period. Yousif Capital Management LLC bought a new stake in shares of DENTSPLY SIRONA during the 4th quarter valued at $2,021,000. CWM LLC bought a new stake in shares of DENTSPLY SIRONA during the 4th quarter valued at $122,000. Finally, Xponance Inc. lifted its position in shares of DENTSPLY SIRONA by 22.3% during the 4th quarter. Xponance Inc. now owns 13,777 shares of the medical instruments supplier’s stock valued at $769,000 after acquiring an additional 2,516 shares during the period. 94.79% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Inc designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces.

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.

BioCryst Pharmaceuticals (NASDAQ:BCRX) Shares Gap Down to $13.74

Citigroup Boosts Werner Enterprises (NASDAQ:WERN) Price Target to $44.00